[1] |
Rankin, S., Ayad, N.G. and Kirschner, M.W. (2005) Sororin, a Substrate of the Anaphase-Promoting Complex, Is Re-quired for Sister Chromatid Cohesion in Vertebrates. Molecular Cell, 18, 185-200. https://doi.org/10.1016/j.molcel.2005.03.017 |
[2] |
Nishiyama, T., Ladurner, R., Schmitz, J., et al. (2010) Sororin Mediates Sister Chromatid Cohesion by Antagonizing Wapl. Cell, 143, 737-749. https://doi.org/10.1016/j.cell.2010.10.031 |
[3] |
Ladurner, R., Kreidl, E., Ivanov, M.P., et al. (2016) Sororin Active-ly Maintains Sister Chromatid Cohesion. The EMBO Journal, 35, 635-653. https://doi.org/10.15252/embj.201592532 |
[4] |
Shen, Z., Yu, X., Zheng, Y., et al. (2018) CDCA5 Regulates Pro-liferation in Hepatocellular Carcinoma and Has Potential as a Negative Prognostic Marker. OncoTargets and Therapy, 11, 891-901. https://doi.org/10.2147/OTT.S154754 |
[5] |
Selig, S., Okumura, K., Ward, D.C., et al. (1992) Delineation of DNA Replication Time Zones by Fluorescence in Situ Hybridization. The EMBO Journal, 11, 1217-1225. https://doi.org/10.1002/j.1460-2075.1992.tb05162.x |
[6] |
Gerlich, D., Koch, B., Dupeux, F., et al. (2006) Live-Cell Imaging Reveals a Stable Cohesin-Chromatin Interaction after but Not before DNA Replication. Current Biology, 16, 1571-1578. https://doi.org/10.1016/j.cub.2006.06.068 |
[7] |
Kueng, S., Hegemann, B., Peters, B.H., et al. (2006) Wapl Controls the Dynamic Association of Cohesin with Chromatin. Cell, 127, 955-967. https://doi.org/10.1016/j.cell.2006.09.040 |
[8] |
Schmitz, J., Watrin, E., Lénárt, P., et al. (2007) Sororin Is Required for Stable Binding of Cohesin to Chromatin and for Sister Chromatid Cohesion in Interphase. Current Biology, 17, 630-636. https://doi.org/10.1016/j.cub.2007.02.029 |
[9] |
Zhang, N. and Pati, D. (2012) Sororin Is a Master Regu-lator of Sister Chromatid Cohesion and Separation. Cell Cycle, 11, 2073-2083. https://doi.org/10.4161/cc.20241 |
[10] |
Waizenegger, I.C., Hauf, S., Meinke, A., et al. (2000) Two Distinct Path-ways Remove Mammalian Cohesin from Chromosome Arms in Prophase and from Centromeres in Anaphase. Cell, 103, 399-410. https://doi.org/10.1016/S0092-8674(00)00132-X |
[11] |
Liu, H., Rankin, S. and Yu, H. (2013) Phosphoryla-tion-Enabled Binding of SGO1-PP2A to Cohesin Protects Sororin and Centromeric Cohesion during Mitosis. Nature Cell Biology, 15, 40-49. https://doi.org/10.1038/ncb2637 |
[12] |
Zhang, N., Panigrahi, A.K., Mao, Q., et al. (2011) Interaction of Sororin Protein with Polo-Like Kinase 1 Mediates Resolution of Chromosomal Arm Cohesion. Journal of Biological Chemistry, 286, 41826-41837. https://doi.org/10.1074/jbc.M111.305888 |
[13] |
Dreier, M.R., Bekier, M.E. and Taylor, W.R. (2011) Regulation of Sororin by Cdk1-Mediated Phosphorylation. Journal of Cell Science, 124, 2976-2987. https://doi.org/10.1242/jcs.085431 |
[14] |
Zhang, N. and Pati, D. (2015) C-Terminus of Sororin Interacts with SA2 and Regulates Sister Chromatid Cohesion. Cell Cycle, 14, 820-826. https://doi.org/10.1080/15384101.2014.1000206 |
[15] |
Zhou, C., Zhang, X., Miao, Y., et al. (2021) The Cohesin Stabilizer Sororin Drives G(2)-M Transition and Spindle Assembly in Mammalian Oocytes. Science Advances, 7, eabg9335. https://doi.org/10.1126/sciadv.abg9335 |
[16] |
Xu, Z., Wang, S., Ren, Z., et al. (2022) An Integrated Analysis of Prognostic and Immune Infiltrates for Hub Genes as Potential Survival Indicators in Patients with Lung Ad-enocarcinoma. World Journal of Surgical Oncology, 20, Article No. 99. https://doi.org/10.1186/s12957-022-02543-z |
[17] |
Chen, Y., Jin, L., Jiang, Z., et al. (2021) Identifying and Validat-ing Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis. Frontiers in Oncology, 11, Ar-ticle ID: 644426. https://doi.org/10.3389/fonc.2021.644426 |
[18] |
Zeng, H., Ji, J., Song, X., et al. (2020) Stemness Related Genes Revealed by Network Analysis Associated with Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma. Frontiers in Genetics, 11, Article ID: 549213. https://doi.org/10.3389/fgene.2020.549213 |
[19] |
Yi, M., Li, T., Qin, S., et al. (2020) Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis. BioMed Research International, 2020, Article ID: 4169691. https://doi.org/10.1155/2020/4169691 |
[20] |
Jiang, N., Zhang, X., Qin, D., et al. (2021) Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication. Frontiers in Genetics, 12, Article ID: 608017. https://doi.org/10.3389/fgene.2021.608017 |
[21] |
Yu, Z., Ma, X., Zhang, W., et al. (2021) Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma. BioMed Research International, 2021, Article ID: 1093702. https://doi.org/10.1155/2021/1093702 |
[22] |
Gao, S., Zhu, D., Zhu, J., et al. (2021) Screening Hub Genes of Hepa-tocellular Carcinoma Based on Public Databases. Computational and Mathematical Methods, 2021, Article ID: 7029130. https://doi.org/10.1155/2021/7029130 |
[23] |
Chen, H., Wu, J., Lu, L., et al. (2020) Identification of Hub Genes As-sociated with Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches. Frontiers in Genetics, 11, Article ID: 575762. https://doi.org/10.3389/fgene.2020.575762 |
[24] |
Wan, Z., Zhang, X., Luo, Y., et al. (2019) Identification of Hepa-tocellular Carcinoma-Related Potential Genes and Pathways through Bioinformatic-Based Analyses. Genetic Testing and Molecular Biomarkers, 23, 766-777. https://doi.org/10.1089/gtmb.2019.0063 |
[25] |
Liu, Z., Pan, R., Li, W., et al. (2021) Comprehensive Analysis of Cell Cycle-Related Genes in Patients with Prostate Cancer. Frontiers in Oncology, 11, Article ID: 796795. https://doi.org/10.3389/fonc.2021.796795 |
[26] |
Lin, K., Zhu, X., Luo, C., et al. (2021) Data Mining Combined with Experiments to Validate CEP55 as a Prognostic Biomarker in Colorectal Cancer. Immunity, Inflammation and Disease, 9, 167-182. https://doi.org/10.1002/iid3.375 |
[27] |
Zhou, Q., Ren, J., Hou, J., et al. (2019) Co-Expression Network Analysis Identified Candidate Biomarkers in Association with Progression and Prognosis of Breast Cancer. Journal of Cancer Research and Clinical Oncology, 145, 2383-2396. https://doi.org/10.1007/s00432-019-02974-4 |
[28] |
Gui, T., Yao, C., Jia, B., et al. (2021) Identification and Analysis of Genes Associated with Epithelial Ovarian Cancer by Inte-grated Bioinformatics Methods. PLOS ONE, 16, e0253136. https://doi.org/10.1371/journal.pone.0253136 |
[29] |
Liu, J., Meng, H., Li, S., et al. (2019) Identification of Potential Biomarkers in Association with Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis. Frontiers in Genetics, 10, Article No. 1031. https://doi.org/10.3389/fgene.2019.01031 |
[30] |
Xing, C., Wang, Z., Zhu, Y., et al. (2021) Integrate Analysis of the Promote Function of Cell Division Cycle-Associated Protein Family to Pancreatic Adenocarcinoma. International Jour-nal of Medical Sciences, 18, 672-684. https://doi.org/10.7150/ijms.53243 |
[31] |
Xu, J., Zhu, C., Yu, Y., et al. (2019) Systematic Cancer-Testis Gene Ex-pression Analysis Identified CDCA5 as a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma. EBio-Medicine, 46, 54-65. https://doi.org/10.1016/j.ebiom.2019.07.030 |
[32] |
Nguyen, M.H., Koinuma, J., Ueda, K., et al. (2010) Phosphory-lation and Activation of Cell Division Cycle Associated 5 by Mitogen-Activated Protein Kinase Play a Crucial Role in Human Lung Carcinogenesis. Cancer Research, 70, 5337-5347. https://doi.org/10.1158/0008-5472.CAN-09-4372 |
[33] |
Fu, G., Xu, Z., Chen, X., et al. (2020) CDCA5 Functions as a Tumor Promoter in Bladder Cancer by Dysregulating Mitochondria-Mediated Apoptosis, Cell Cycle Regulation and PI3k/AKT/mTOR Pathway Activation. Journal of Cancer, 11, 2408-2420. https://doi.org/10.7150/jca.35372 |
[34] |
Ji, J., Shen, T., Li, Y., et al. (2021) CDCA5 Promotes the Progression of Prostate Cancer by Affecting the ERK Signalling Pathway. Oncology Reports, 45, 921-932. https://doi.org/10.3892/or.2021.7920 |
[35] |
Chong, Y. and Xue, L. (2021) Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells. Critical Reviews™ in Eu-karyotic Gene Expression, 31, 29-40. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2020036803 |
[36] |
Huang, X., Huang, Y., Lv, Z., et al. (2022) Loss of Cell Division Cycle-Associated 5 Promotes Cell Apoptosis by Activating DNA Damage Response in Clear Cell Renal Cell Carcinoma. International Journal of Oncology, 61, Article No. 87. https://doi.org/10.3892/ijo.2022.5377 |
[37] |
Tokuzen, N., Nakashiro, K., Tanaka, H., et al. (2016) Therapeutic Po-tential of Targeting Cell Division Cycle Associated 5 for Oral Squamous Cell Carcinoma. Oncotarget, 7, 2343-2353. https://doi.org/10.18632/oncotarget.6148 |
[38] |
Chen, T., Huang, Z., Tian, Y., et al. (2017) Role of Triosephosphate Isomerase and Downstream Functional Genes on Gastric Cancer. Oncology Reports, 38, 1822-1832. https://doi.org/10.3892/or.2017.5846 |
[39] |
Kato, T., Lee, D., Wu, L., et al. (2016) SORORIN and PLK1 as Poten-tial Therapeutic Targets in Malignant Pleural Mesothelioma. International Journal of Oncology, 49, 2411-2420. https://doi.org/10.3892/ijo.2016.3765 |
[40] |
Li, Y., Peng, W., Deng, Y., et al. (2022) Effect of CDCA5 on Prolifera-tion and Metastasis of Triple Negative Breast Cancer Cells under shRNA Interference Technology. Journal of Oncology, 2022, Article ID: 9038230. https://doi.org/10.1155/2022/9038230 |
[41] |
Hu, H., Xiang, Y., Zhang, X.Y., et al. (2022) CDCA5 Promotes the Progression of Breast Cancer and Serves as a Potential Prognostic Biomarker. Oncology Reports, 48, 172. https://doi.org/10.3892/or.2022.8387 |
[42] |
Hou, S., Chen, X., Li, M., et al. (2020) Higher Expression of Cell Divi-sion Cycle-Associated Protein 5 Predicts Poorer Survival Outcomes in Hepatocellular Carcinoma. Aging (Albany NY), 12, 14542-14555. https://doi.org/10.18632/aging.103501 |
[43] |
Bai, L., Ren, Y. and Cui, T. (2020) Overexpression of CDCA5, KIF4A, TPX2, and FOXM1 Coregulated Cell Cycle and Promoted Hepatocellular Carcinoma Development. Journal of Computational Biology, 27, 965-974. https://doi.org/10.1089/cmb.2019.0254 |
[44] |
Wang, J., Xia, C., Pu, M., et al. (2018) Silencing of CDCA5 Inhibits Cancer Progression and Serves as a Prognostic Biomarker for Hepatocellular Carcinoma. Oncology Reports, 40, 1875-1884. https://doi.org/10.3892/or.2018.6579 |
[45] |
Chen, H., Chen, J., Zhao, L., et al. (2019) CDCA5, Tran-scribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma. Journal of Cancer, 10, 1846-1854. https://doi.org/10.7150/jca.28809 |
[46] |
Shen, A., Liu, L., Chen, H., et al. (2019) Cell Division Cycle Associated 5 Promotes Colorectal Cancer Progression by Activating the ERK Signaling Pathway. Oncogenesis, 8, Article No. 19. https://doi.org/10.1038/s41389-019-0123-5 |
[47] |
Kariri, Y.A., Joseph, C., Alsaleem, M.A., et al. (2022) Mechanis-tic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predic-tor of Outcome in Invasive Breast Cancer. Cancers (Basel), 14, Article No. 5643. https://doi.org/10.3390/cancers14225643 |
[48] |
Shen, W., Tong, D., Chen, J., et al. (2022) Silencing Oncogene Cell Division Cycle Associated 5 Induces Apoptosis and G1 Phase Arrest of Non-Small Cell Lung Cancer Cells via p53-p21 Signaling Pathway. Journal of Clinical Laboratory Analysis, 36, e24396. https://doi.org/10.1002/jcla.24396 |
[49] |
Luo, Z., Wang, J., Zhu, Y., et al. (2021) SPOP Promotes CDCA5 Degra-dation to Regulate Prostate Cancer Progression via the AKT Pathway. Neoplasia, 23, 1037-1047. https://doi.org/10.1016/j.neo.2021.08.002 |
[50] |
Zhang, Z., Shen, M. and Zhou, G. (2018) Upregulation of CDCA5 Promotes Gastric Cancer Malignant Progression via Influencing Cyclin E1. Biochemical and Biophysical Research Communications, 496, 482-489. https://doi.org/10.1016/j.bbrc.2018.01.046 |
[51] |
Gao, A., Hu, Y. and Zhu, W. (2021) CDCA5 Is Negatively Regu-lated by miR-326 and Boosts Ovarian Cancer Progression. Journal of BUON, 26, 544-552. |
[52] |
Chen, C., Chen, S., Luo, M., et al. (2020) The Role of the CDCA Gene Family in Ovarian Cancer. Annals of Translational Medicine, 8, 190. https://doi.org/10.21037/atm.2020.01.99 |
[53] |
Liu, D., Gong, H., Tao, Z., et al. (2021) LINC01515 Promotes Na-sopharyngeal Carcinoma Progression by Serving as a Sponge for miR-325 to Up-Regulate CDCA5. Journal of Molecu-lar Histology, 52, 577-587. https://doi.org/10.1007/s10735-021-09969-x |
[54] |
Chang, I.W., Lin, V.C., He, H.L., et al. (2015) CDCA5 Overex-pression Is an Indicator of Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Uri-nary Bladder. American Journal of Translational Research, 7, 710-722. |
[55] |
Jin, X., Wang, D., Lei, M., et al. (2022) TPI1 Activates the PI3K/AKT/mTOR Signaling Pathway to Induce Breast Cancer Progression by Stabilizing CDCA5. Journal of Translational Medicine, 20, Article No. 191. https://doi.org/10.1186/s12967-022-03370-2 |
[56] |
Wu, Z.H., Fang, M. and Zhou, Y. (2020) Comprehensive Anal-ysis of the Expression and Prognosis for CDCAs in Head and Neck Squamous Cell Carcinoma. PLOS ONE, 15, e0236678. https://doi.org/10.1371/journal.pone.0236678 |
[57] |
Tian, Y., Wu, J., Chagas, C., et al. (2018) CDCA5 Overexpression Is an Indicator of Poor Prognosis in Patients with Hepatocellular Carcinoma (HCC). BMC Cancer, 18, Article No. 1187. https://doi.org/10.1186/s12885-018-5072-4 |
[58] |
Cai, C., Wang, W. and Tu, Z. (2019) Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma. Journal of Cancer, 10, 355-366. https://doi.org/10.7150/jca.27832 |
[59] |
Huang, Z., Zhang, S., Du, J., et al. (2020) Cyclin-Dependent Ki-nase 1 (CDK1) Is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803. Medical Science Monitor, 26, e923664. https://doi.org/10.12659/MSM.923664 |
[60] |
Wang, Z., Fan, M., Candas, D., et al. (2014) Cyclin B1/Cdk1 Coordi-nates Mitochondrial Respiration for Cell-Cycle G2/M Progression. Developmental Cell, 29, 217-232. https://doi.org/10.1016/j.devcel.2014.03.012 |
[61] |
Fang, Y., Yu, H., Liang, X., et al. (2014) Chk1-Induced CCNB1 Overexpression Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer. Cancer Biology & Therapy, 15, 1268-1279. https://doi.org/10.4161/cbt.29691 |
[62] |
Zhang, N., Coutinho, L.E. and Pati, D. (2021) PDS5A and PDS5B in Co-hesin Function and Human Disease. International Journal of Molecular Sciences, 22, Article No. 5868. https://doi.org/10.3390/ijms22115868 |
[63] |
Hagemann, C., Weigelin, B., Schommer, S., et al. (2011) The Cohe-sin-Interacting Protein, Precocious Dissociation of Sisters 5A/Sister Chromatid Cohesion Protein 112, Is Up-Regulated in Human Astrocytic Tumors. International Journal of Molecular Medicine, 27, 39-51. https://doi.org/10.3892/ijmm.2010.551 |
[64] |
Wang, Y., Yao, J., Zhu, Y., et al. (2022) Knockdown of CDCA5 Suppresses Malignant Progression of Breast Cancer Cells by Regulating PDS5A. Molecular Medicine Reports, 25, Arti-cle No. 209. https://doi.org/10.3892/mmr.2022.12725 |
[65] |
Koedoot, E., van Steijn, E., Vermeer, M., et al. (2021) Splicing Fac-tors Control Triple-Negative Breast Cancer Cell Mitosis through SUN2 Interaction and Sororin Intron Retention. Journal of Experimental & Clinical Cancer Research, 40, Article No. 82. https://doi.org/10.1186/s13046-021-01863-4 |
[66] |
Yang, T., Li, Y., Wang, G., et al. (2022) lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression. BioMed Research International, 2022, Article ID: 3858249. https://doi.org/10.1155/2022/3858249 |
[67] |
Zhang, X., Yan, Z., Wang, L., et al. (2020) STAT1-Induced Upregula-tion of lncRNA RHPN1-AS1 Predicts a Poor Prognosis of Hepatocellular Carcinoma and Contributes to Tumor Pro-gression via the miR-485/CDCA5 Axis. Journal of Cellular Biochemistry, 121, 4741-4755. https://doi.org/10.1002/jcb.29689 |
[68] |
Fu, Y., Zhou, Q.Z., Zhang, X.L., et al. (2019) Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages. Medical Science Monitor, 25, 8873-8890. https://doi.org/10.12659/MSM.919046 |
[69] |
Xu, T., Ma, M., Dai, J., et al. (2018) Gene Expression Screening Identifies CDCA5 as a Potential Therapeutic Target in Acral Melanoma. Human Pathology, 75, 137-145. https://doi.org/10.1016/j.humpath.2018.02.009 |
[70] |
Wu, Q., Zhang, B., Sun, Y., et al. (2019) Identification of Novel Biomarkers and Candidate Small Molecule Drugs in Non-Small-Cell Lung Cancer by Integrated Microarray Analysis. OncoTargets and Therapy, 12, 3545-3563. https://doi.org/10.2147/OTT.S198621 |
[71] |
Wu, B., Huang, Y., Luo, Y., et al. (2020) The Diagnostic and Prognos-tic Value of Cell Division Cycle Associated Gene Family in Hepatocellular Carcinoma. Journal of Cancer, 11, 5727-5737. https://doi.org/10.7150/jca.46554 |
[72] |
Wang, Y., Yang, Y., Gao, H., et al. (2020) Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology, 10, Article ID: 566183. https://doi.org/10.3389/fonc.2020.566183 |
[73] |
Lin, Y., Liang, R., Ye, J., et al. (2019) A Twenty Gene-Based Gene Set Variation Score Reflects the Pathological Progression from Cirrhosis to Hepatocellular Carcinoma. Aging (Albany NY), 11, 11157-11169. https://doi.org/10.18632/aging.102518 |